Related by context. All words. (Click for frequent words.) 80 ovarian cancers 77 prostate cancers 77 colorectal cancer 77 colon cancers 76 breast cancers 76 pancreatic cancers 74 bladder cancers 74 lung cancers 74 cancers 71 endometrial cancers 70 bowel cancers 69 cervical cancers 69 ovarian cancer 68 rectal cancers 67 invasive breast cancer 66 adenocarcinoma 66 colorectal cancer CRC 66 colon cancer 66 gastric cancer 65 gastric cancers 65 melanoma 65 malignancy 65 esophageal cancers 65 malignancies 65 cervical breast 65 lobular carcinoma 65 melanomas 65 lung cancer 65 uterine cancers 65 testicular cancers 65 breast tumors 64 squamous cell carcinoma 64 cervical cancer 64 squamous cell carcinomas 64 rectal cancer 64 gynecologic cancers 64 prostate cancer 64 nonmelanoma skin cancers 64 adenocarcinomas 63 pleural mesothelioma 63 breast cancer 63 endometrial cancer 63 carcinoma 63 invasive cervical cancer 63 pre cancerous lesions 63 colorectal 63 ductal cancer 63 oropharyngeal cancer 63 breast ovarian 63 HER2 positive breast cancer 63 gastrointestinal cancers 63 precursor lesions 63 gynecological cancers 62 lobular cancer 62 colorectal tumors 62 adenomatous polyps 62 NSCLC 62 skin cancers 62 basal cell carcinomas 62 Colorectal cancer 61 BRCA2 mutations 61 lymphomas 61 HNSCC 61 adenomas 61 prostate cancer CaP 61 malignant melanoma 61 adenoma 61 metastatic disease 61 advanced adenoma 61 CaP 61 metastases 61 malignant pleural mesothelioma 61 BRCA mutations 61 GISTs 61 thyroid cancers 61 atypical hyperplasia 61 pancreatic adenocarcinoma 61 nonmelanoma skin cancer 61 liver metastases 61 carcinomas 61 lung colorectal 61 lobular breast cancer 60 squamous cell cancers 60 breast carcinomas 60 lung adenocarcinoma 60 gynecologic cancer 60 HER2 positive 60 lung tumors 60 Renal cell carcinoma 60 seminoma 60 cervical carcinoma 60 precancerous lesions 60 prostate breast 60 ovarian breast 60 tumors 60 hereditary breast cancer 60 situ LCIS 60 pre cancerous polyps 60 colorectal polyps 60 colon breast 60 squamous cell 60 bladder cancer 60 colorectal adenomas 60 precancers 60 anal cancers 60 basal cell carcinoma BCC 60 advanced adenomas 59 metastatic prostate cancer 59 neoplasms 59 HPV infection 59 ovarian tumors 59 renal cell carcinomas 59 cervical lesions 59 Barrett esophagus 59 pancreatic lung 59 nonsmall cell lung cancer 59 breast endometrial 59 liver cancer 59 HPV 59 hepatocellular carcinoma 59 neuroendocrine tumors 59 situ DCIS 59 prostate lung 59 Gastric cancer 59 prostate tumors 59 PCa 59 Ovarian cancer 59 neoplasia 59 colon tumors 59 oesophageal cancer 59 HPV infections 58 distant metastases 58 renal cell carcinoma 58 cancer 58 mesotheliomas 58 Basal cell carcinoma 58 invasive carcinoma 58 tumor recurrence 58 colorectal polyp 58 colorectal breast 58 benign breast 58 cutaneous melanoma 58 breast cancer recurrence 58 uveal melanoma 58 osteosarcomas 58 soft tissue sarcomas 57 prostate ovarian 57 ALCL 57 bowel cancer 57 squamous cell cancer 57 esophageal adenocarcinoma 57 malignant melanomas 57 Prostate cancer 57 familial pancreatic cancer 57 penile cancers 57 curable cancers 57 endometrial hyperplasia 57 BRCA1 mutations 57 hepatocellular cancer 57 precancerous polyps 57 Lung cancer 57 breast prostate 57 serous ovarian cancer 57 metastatic cancer 57 precancerous cervical lesions 57 metastatic colorectal 57 NAFLD 57 prostate pancreatic 57 breast uterine 57 distant metastasis 57 uterine ovarian 57 invasive ductal 57 epithelial tumors 57 hormone receptor positive 57 metastatic cancers 57 neoplasias 57 genital herpes infections 57 bone metastasis 57 epithelial ovarian cancer 57 venous blood clots 57 Colorectal cancers 57 HNPCC 57 ovarian lung 57 hamartomas 57 cell carcinoma 57 breast pancreatic 57 colorectal carcinoma 57 breast colon 57 HPV# 57 malignant growths 56 medullary thyroid cancer 56 diffuse gastric 56 distal colon cancer 56 gastric adenocarcinoma 56 pharyngeal cancer 56 invasive ductal carcinoma 56 prostate colon 56 lung pancreatic 56 colorectal lung 56 squamous cell skin 56 Colon polyps 56 Cholangiocarcinoma 56 ductal breast cancer 56 CIN2 + 56 carcinoid tumors 56 lymph node metastases 56 brain metastases 56 DCIS 56 HCV infection 56 Squamous cell 56 micrometastases 56 oesophageal adenocarcinoma 56 breast carcinoma 56 breast colorectal 56 ductal carcinomas 56 BRCA2 56 cervical intraepithelial neoplasia 56 human papillomavirus HPV 56 HPV types 56 basal cell carcinoma 56 grade gliomas 56 intestinal polyps 56 Adenocarcinoma 56 pre cancerous 56 peritoneal cancer 56 benign proliferative breast 56 hepatocellular carcinoma HCC 56 ductal adenocarcinoma 56 CIN3 + 56 prostate specific 56 premalignant 56 laryngeal cancer 56 breast cervical 56 ductal carcinoma 56 Stomach cancer 56 prostate adenocarcinoma 56 skeletal metastases 56 nasopharyngeal cancer 56 pancreatic cancer 56 chlamydial infection 56 nasopharyngeal carcinoma 56 basal cell cancer 56 HGPIN 56 lung adenocarcinomas 56 Carcinoma 55 FSGS 55 benign growths 55 HCV infections 55 ovarian pancreatic 55 malignant tumors 55 commonly mutated genes 55 liver metastasis 55 cervical uterine 55 Cancers 55 CMV disease 55 colon rectal cancer 55 GBM tumors 55 BRCA2 gene mutation 55 squamous cell lung cancer 55 colorectal neoplasia 55 pre cancerous growths 55 malignant mesothelioma 55 metastatic breast cancer 55 Cervical cancer 55 cell lung cancer 55 ErbB2 positive 55 carcinoid cancer 55 periodontitis 55 cardiovascular disease 55 breast cancer recurrences 55 basal cell nevus syndrome 55 invasive cervical cancers 55 ccRCC 55 basal cell cancers 55 Uterine cancer 55 metastasis 55 Inflammatory breast cancer 55 Rectal cancer 55 leukaemias 55 metastatic lung cancer 55 colon polyps 55 lung prostate 55 sarcoma 55 squamous cell carcinoma SCC 55 melanoma skin 55 BRCA mutation 55 EGFR mutation 55 precancerous 55 ADPKD 55 urothelial carcinoma 55 metastatic 55 neuroblastomas 55 localized prostate cancer 55 Testicular cancer 55 osteoporotic fractures 55 colorectal cancer screening 55 MGUS 55 Renal Cell Carcinoma RCC 55 carcinoid 55 cholangiocarcinoma 55 solar keratosis 55 Bladder cancer 55 leiomyomas 55 leiomyosarcoma 55 metastatic lesions 55 systemic scleroderma 55 postmenopausal breast cancer 55 Basal cell 55 premalignant lesions 55 BRCA2 mutation 54 Glioblastoma 54 basal cell 54 locoregional recurrence 54 advanced neoplasia 54 colorectal adenoma 54 molecular abnormalities 54 ovarian carcinoma 54 Thyroid nodules 54 Adjuvant chemotherapy 54 metastatic melanoma 54 Bowel cancer 54 vulvar cancers 54 endometrial ovarian 54 peritoneal carcinomatosis 54 precancerous tumors 54 metachronous 54 adenoid cystic carcinoma 54 prostrate cancer 54 testicular germ cell 54 Hepatocellular carcinoma 54 precancer 54 faulty BRCA genes 54 H. pylori 54 esophageal cancer 54 genes BRCA1 54 invasive pneumococcal disease 54 papillary renal cell carcinoma 54 digestive tract cancers 54 ovarian endometrial 54 benign polyps 54 estrogen receptor negative 54 BRCA2 mutation carriers 54 gastrointestinal stromal tumors 54 renal tumors 54 colorectal gastric 54 Ductal carcinoma 54 differentiated thyroid 54 malignant neoplasm 54 fibroadenomas 54 axillary dissection 54 epithelial cancers 54 cancerous lesions 54 Malignant melanoma 54 BRCA deficient 54 metastatic colorectal cancer 54 de ath 54 antigen PSA 54 Endometrial cancer 54 malignant lesions 54 bone metastases 54 colon esophageal 54 Helicobacter pylori infection 54 recurrent ovarian cancer 54 lung colon 54 pancreatic colorectal 54 ALK mutations 54 colon rectum 54 cancerdefine 54 ovarian 54 transitional cell carcinoma 54 colorectal prostate 54 bladder prostate 54 Esophageal cancer 54 ovarian prostate 54 S. aureus infections 54 medulloblastomas 54 polyp recurrence 54 cervical dysplasia 53 FGFR2 53 cutaneous squamous cell carcinoma 53 colorectal bowel 53 lobular carcinomas 53 pre malignant lesions 53 Colorectal cancer CRC 53 precancerous cervical 53 endometrial carcinoma 53 metastatic colon cancer 53 BRCA1 53 ASCUS 53 atypia 53 Epithelial ovarian cancer 53 PARP inhibition 53 nonmetastatic 53 pancreatic prostate 53 KRAS mutation 53 malignant lymphoma 53 gallstone disease 53 metastatic tumors 53 EGFR mutations 53 oesophageal cancers 53 glioblastoma 53 specific antigen 53 Squamous cell carcinomas 53 nonmelanoma 53 pulmonary metastases 53 pilocytic astrocytomas 53 CMV infection 53 BRCA1 mutation carriers 53 pancreatic NET 53 colonic polyps 53 TGFBR1 * 6A 53 bladder tumors 53 contralateral breast cancer 53 solid tumors 53 non Hodgkin lymphomas 53 mutated BRCA1 53 gastric cardia 53 familial ALS 53 grade cervical intraepithelial 53 Acute myeloid leukemia 53 H. pylori infection 53 acute myelogenous leukemia AML 53 EUS FNA 53 HPV genotypes 53 renal carcinoma 53 follicular lymphoma 53 anaplastic 53 adjuvant therapy 53 HER2 overexpression 53 Pancreatic neuroendocrine tumors 53 metastatic prostate 53 Melanoma 53 Colorectal 53 Papillary 53 Hepatocellular Carcinoma HCC 53 axillary lymph nodes 53 urothelial cancer 53 cervix uteri 53 synovial sarcoma 53 lobular involution 53 colon pancreas 53 prostate carcinoma 53 Non Hodgkin lymphoma 53 neuroendocrine cancers 53 Breast cancer 53 polyps 53 nodular melanoma 53 atypical ductal hyperplasia 53 metastatic HER2 positive 53 BRAF mutations 53 pancreatic tumors 53 medically inoperable 53 sarcomas 53 colon pancreatic 53 colorectal bladder 53 vaginal cancers 53 heart disease 53 gynecologic malignancy 53 Pap smear screening 53 breast cancer susceptibility genes 53 colorectal pancreatic 53 vulvar cancer 53 DLBCL 53 histological subtype 53 hypopharynx 52 hormone receptor negative 52 Digital Mammographic Imaging 52 meningiomas 52 BRCA mutation carriers 52 BRCA2 gene mutations 52 oropharyngeal cancers 52 adjuvant radiation 52 angiosarcoma 52 esophageal squamous cell carcinoma 52 neoadjuvant therapy 52 malignant polyps 52 gene BRCA2 52 BRCA genes 52 intestinal metaplasia 52 Cristofanilli 52 metastatic melanomas 52 colon prostate 52 Pancreatic cancer 52 precancerous polyp 52 gynecological cancer 52 metastatic renal cell carcinoma 52 chlamydia infection 52 paragangliomas 52 HER2 positive cancers 52 breast cancer genes BRCA1 52 disease 52 Oesophageal cancer 52 mucinous 52 Squamous 52 Chronic lymphocytic leukemia 52 CIN3 52 Epstein Barr virus EBV 52 biliary cancer 52 Human papilloma virus 52 melanoma tumors 52 NMP# 52 pelvic malignancies 52 H pylori 52 nonalcoholic steatohepatitis NASH 52 histologies 52 geographic atrophy 52 colorectal neoplasms 52 PSA screening 52 sporadic ALS 52 PCNSL 52 VTE 52 specific antigen PSA 52 tumor subtypes 52 mammary tumors 52 gliomas 52 colorectal cancer incidence 52 colo rectal cancer 52 GNAQ 52 squamous 52 thyroid nodules 52 prostate cancer PCa 52 adenomatous polyp 52 uterine cancer 52 pancreatic bladder 52 pCR 52 Hepatocellular carcinoma HCC 52 estrogen receptor positive 52 endometrial kidney 52 neuroendocrine carcinoma 52 Acute lymphoblastic leukemia 52 abnormal growths 52 GIST 52 glioblastomas 52 p# mutations 52 malignant transformation 52 MALT lymphoma 52 serrated polyps 52 curative resection 52 BRAF gene 52 pre cancerous cells 52 myelodysplastic syndrome MDS 52 ductal lobular 52 metastatic bladder 52 prostate tumor 52 lung carcinomas 52 T1c 52 untreated celiac disease 52 GIST tumors 52 adjuvant radiotherapy 52 chronic HBV infection 52 HER2 positive tumors 52 gastrointestinal malignancies 52 Brain metastases 52 cisplatin resistant 52 Wilms tumor 52 Medullary thyroid cancer 52 contralateral breast 52 H. pylori eradication 52 tumor metastases 52 prostate colorectal 52 papillary 52 CYT# potent vascular disrupting 52 pheochromocytomas 52 germline mutations 52 choriocarcinoma 52 breast lesions 52 oesophageal squamous cell carcinoma 52 external genital lesions 52 Metastatic breast cancer 52 laryngeal cancers 52 histologic subtype 52 pancreatic ovarian 52 Metastatic 52 colorectum 52 invasive lobular 52 epithelial ovarian 52 LQTS 52 Gliomas 52 Malignant Melanoma 52 BRCA1 BRCA2 52 Chlamydia infection 52 oophorectomy 52 urothelial bladder cancer 52 leukemia ALL 52 Uterine fibroids 52 malignant neoplasms 52 premenopausal breast cancer 52 node metastases 51 Colon Cancer 51 Polyps 51 fecal occult blood 51 Li Fraumeni 51 benign noncancerous 51 S. aureus infection 51 thromboembolic events 51 Prostate Cancer Prostate 51 breast ovary 51 lung metastases 51 coronary disease 51 cancerous polyps 51 Adenomas 51 familial adenomatous polyposis 51 esophageal tumors 51 gastrectomy 51 KRAS mutations occur 51 ovarian uterine 51 SCCHN 51 imatinib resistance 51 breast cancer metastasis 51 SLNB 51 neoadjuvant chemotherapy 51 resectable 51 Metastases 51 basal cell skin 51 endocrine tumors 51 ischemic strokes 51 gastrointestinal stromal tumor 51 proliferative diabetic retinopathy 51 venous thrombosis 51 operable breast cancer 51 BRCA2 carriers 51 Human Papilloma Virus 51 HER2 + 51 radical nephrectomy 51 adjuvant therapies 51 Colorectal cancer screening 51 Menopausal hormone therapy 51 APOL1 51 endometrial tumors 51 asymptomatic 51 MSH2 51 NNRTI resistance 51 coronary artery disease 51 neovascular AMD 51 proximal colon 51 oligodendrogliomas 51 frequently benign tumor 51 Tumours 51 HER2 51 hypermethylation 51 microdeletions 51 HBeAg negative 51 subclinical hyperthyroidism 51 commonest cancers 51 Hodgkin lymphoma HL 51 cytoreduction 51 FGFR2 gene 51 Paget disease 51 inherited mutations 51 multiple myeloma 51 leukemias 51 hormone therapy estrogen 51 benign lesions 51 Sjögren syndrome 51 MYCN amplification 51 liposarcoma 51 oropharyngeal squamous cell carcinoma 51 adrenocortical cancer 51 gastrointestinal stromal tumors GISTs 51 postoperative pathology 51 recurrent metastatic 51 lobular 51 recurrent ovarian 51 pancreatic colon 51 fallopian tube carcinoma 51 sarcosine 51 B7 H3 51 intravenous bisphosphonates 51 lymphoma 51 mammographic density 51 mtDNA mutations 51 COPD 51 Plasmodium falciparum 51 Merkel cell carcinoma 51 non Hodgkin lymphoma 51 Periodontal disease 51 alpha carotene 51 ovarian cervical 51 ovarian colorectal 51 advanced hepatocellular carcinoma 51 neoplasia PIN 51 carcinoid tumor 51 metastatic adenocarcinoma 51 prostate bladder 51 superficial bladder cancer 51 mutated KRAS gene 51 metastatic gastric 51 glioma rarer 51 preoperative chemotherapy 51 medulloblastoma 51 AAT deficiency 51 PSADT 51 screening mammography 51 elevated triglyceride levels 51 invasive ductal carcinomas 51 Carcinoid tumors 51 GnRH agonists 51 brain tumors 51 adenomatous 51 tumor histology 51 ependymoma 51 Radical prostatectomy 51 NSCLC tumors 51 seminomas 51 CDH1 51 Follicular lymphoma 51 cardio vascular disease 51 gastric carcinoma 51 colon cancer screening 51 bile duct cancers 51 invasive ductal breast cancer 51 dysplastic lesions caused 51 incidentalomas 51 abnormal mammograms 51 Helicobacter pylori 51 dietary folate intake 51 gene mutations 50 resistant hormone refractory 50 Her2 50 Seewaldt 50 carcinoma HNSCC 50 hyperplastic polyps 50 heavily pretreated 50 BRAF mutation 50 castration resistant prostate cancer 50 pT2 50 endostatin 50 anti angiogenic therapy 50 CIN2 50 detect precancerous lesions 50 hepatocellular carcinomas 50 soft tissue sarcoma 50 estrogen progestin therapy 50 breast conserving 50 neoadjuvant treatment 50 papillary carcinoma 50 acute leukemias 50 gynecological malignancies 50 recurrent NSCLC 50 Malignant mesothelioma 50 recurrences 50 Cell Lung Cancer 50 malignant gliomas 50 pre menopausal 50 candidemia 50 microalbuminuria 50 aneuploidy 50 taxane therapy 50 invasive lobular carcinoma 50 breast caner 50 invasive carcinomas 50 Glioma 50 mycobacterial infections 50 alveolar rhabdomyosarcoma 50 thromboembolic disease 50 CC genotype 50 cell lymphomas 50 hereditary predisposition 50 axillary node dissection 50 testicular tumors 50 elevated CRP 50 pancreatic tumor 50 Squamous cell carcinoma 50 atrophic gastritis 50 leukemia AML 50 pharyngeal cancers 50 chromosomal abnormalities 50 Malignant gliomas 50 extracolonic findings 50 Trichomonas vaginalis 50 Recurrences 50 intensive statin therapy 50 CLL 50 colorectal liver metastases 50 leukemias lymphomas 50 Melanomas 50 Chronic myeloid leukemia 50 colorectal tumor 50 malignant brain 50 atherosclerotic lesions 50 total thyroidectomy 50 PROLARIS 50 Glioblastoma Multiforme GBM 50 abnormal Pap smears 50 neoplasm 50 cancerous enlargement 50 oesophageal 50 K ras mutations 50 cirrhosis liver failure 50 human papillomavirus 50 metastatic pancreatic 50 prophylactic mastectomy 50 glioma 50 ovarian colon 50 precancerous colon polyps 50 Anal cancer 50 prostate cancer CRPC 50 H. pylori infections 50 latent TB infection 50 chlamydial infections 50 TT genotype 50 recurrent VTE 50 anal lesions 50 neuroblastoma tumors 50 pituitary adenomas 50 cell carcinomas 50 grade serous ovarian 50 BRCA1 mutation 50 paraganglioma 50 esophagus colon 50 gemcitabine chemotherapy 50 castrate resistant 50 Glioblastomas 50 hormonal therapies 50 methylation markers 50 cervical vulvar 50 liver fibrosis 50 atherosclerosis 50 dysglycemia 50 premalignant lesion 50 hypermethylated 50 bacteraemia 50 pathogenic mutations 50 lipid abnormalities 50 PSA velocity 50 lung cancer NSCLC 50 chronic periodontitis 50 GSTP1 50 respiratory viral infections 50 diverticular bleeding 50 Chlamydia trachomatis 50 adenoma recurrence 50 esophagogastric junction 50 myeloproliferative diseases 50 T1a 50 overexpress HER2 50 Thyroid cancer 50 histologic subtypes 50 intraepithelial neoplasia 50 Osteosarcoma 50 pneumococcal infection 50 embryonal rhabdomyosarcoma 50 Prostate Cancer 50 Barrett Esophagus 50 venous thromboembolism 50 KRAS oncogene 50 Candida infection 50 Pancreatic Cancer 50 colon lung 50 IV melanoma 50 mesothelioma 50 neoplastic lesions 50 atherothrombosis 50 endometrial 50 prostate cancer mCRPC 50 symptomless 50 Human papillomavirus HPV 50 mammography screening 50 sarcomatoid 50 LRP5 50 rs# [002] 50 preterm delivery 50 HLA B# 50 Colorectal cancer incidence 50 olaparib 50 EGFR inhibitors 50 Metastatic melanoma 50 chronic prostatitis 50 chemoradiation 50 HER2 positivity 50 carotid stenosis 50 preterm births 50 hormonal therapy 50 carcinoids 50 lymph node removal 50 NMIBC 50 chemoradiotherapy 50 radiation therapy SBRT 50 Human Papillomavirus 50 hormonally sensitive 50 bowel polyps 50 vaginal lesions 50 glioblastoma multiforme 50 HER2 positive metastatic breast 50 invasive meningococcal disease 50 simplex virus 50 cervical ovarian 49 carcinoma HCC 49 prostate specific antigen 49 alcoholic cirrhosis 49 anaplastic lymphoma kinase 49 ZNF# 49 Flexi Scope 49 relapsed ovarian cancer 49 metastatic basal cell 49 Li Fraumeni syndrome 49 ductal 49 benign nodules 49 disease NAFLD 49 asymptomatic carotid stenosis 49 gonococcal infection 49 pneumococcus 49 Velcade bortezomib 49 PTEN mutations 49 BRCA gene mutations 49 Haptoglobin 49 myelofibrosis polycythemia vera 49 bilateral oophorectomy 49 Glioblastoma Multiforme 49 pneumococcal pneumonia 49 IV malignant melanoma 49 bladder ovarian 49 Invasive Breast Cancer 49 Burkitt lymphoma 49 TACI mutations 49 Pleural mesothelioma 49 Non Hodgkins lymphoma 49 metastatic carcinoma 49 TP# gene 49 undergone radical prostatectomy 49 idiopathic myelofibrosis 49 pneumococci 49 recurrent prostate cancer 49 HER2 positive breast 49 BRCA1 gene 49 ocular toxicity 49 salpingo oophorectomy 49 Kaposi sarcoma 49 colon rectal 49 HER-2/neu 49 telomere lengths 49 EBRT 49 oncogenic HPV types 49 gastric pancreatic 49 gefitinib 49 testicular cancer 49 diverticulosis 49 BCCs 49 genetic variants associated 49 epithelioid 49 AA amyloidosis 49 minimally symptomatic metastatic castrate 49 lymphoproliferative disorders 49 abnormal Pap tests 49 presymptomatic 49 breast cancer subtypes 49 Chronic myeloid leukemia CML 49 abnormal Pap 49 APOE e4 gene 49 PGDH 49 glioblastoma multiforme GBM 49 neuro degenerative disease 49 atherosclerotic disease 49 Endometrial 49 locoregional 49 hemorrhagic strokes 49 malignant fibrous histiocytoma 49 prostate carcinomas 49 cancerous tumors 49 HER2 amplified 49 lymphatic tissue 49 unresectable tumors 49 pneumococcal strains 49 cervical neoplasia 49 NF1 49 FTLD 49 onset Alzheimer disease 49 IDH1 mutation 49 atopic disease 49 P. vivax malaria 49 colorectal carcinomas 49 MYH9 gene 49 ovulatory infertility 49 narcolepsy cataplexy 49 Glioblastoma multiforme GBM 49 NP CRNs 49 RNAi therapeutic targeting 49 mutations 49 ARVD 49 lignan intake 49 common hematologic malignancy 49 non squamous NSCLC 49 BRAF V#E 49 cardiovascular disease CVD 49 ALND 49 pancreatic carcinoma 49 HbF 49 ovary uterus 49 CDI recurrence 49 familial hypercholesterolemia 49 sentinel nodes 49 myeloproliferative neoplasms 49 kidney urologic 49 precancerous growths 49 Tay Sachs thalassemia 49 inherited predisposition 49 EGFR gene 49 Synovial sarcoma 49 detecting colorectal cancer